Fighting disease with disease. by unknown
ENVIRONEWS Forum The measure ofthe land and the measure ofour bodies are the same ...
I never said the landwas mine to do with as I chose. The onewho has
the right to dispose ofit is the one who created it.
ChiefJoseph, Nez Perce
EPA Releases Mercury Report
December 19 was a bigdayfor the U.S. EPA.
On that day, after several years ofdebate and
angst, the EPA released the draft copy of its
Reportto CongressonMercury, aneight-volume
reviewofthehazards ofmercury, indudingan
inventory of exposures and health effects
caused by mercury emissions. The EPA calls
its report a "snapshot" ofthe current state of
mercury emissions-and of the current body
ofknowledge on the topic, which only very
recently expanded to include information
from studies conducted in the Seychelle
Islands and the FaroeIslands.
There is no longer anydoubt thatexposure
to mercury, particularly to the organic form
methylmercury, causes damaging health effects,
but there is fierce debate over what level of
exposure should be considered dangerous. The
EPA report, which was originally due in 1994,
was repeatedly held up in hopes ofinduding
data from more recent studies, such as the
Seychelles study. The agency finally decided to
release the reportwithout those data; the report
relies instead largely upon a study from the
early 1970s ofIraqi mother-child pairs, which
found that the presence of mercury in the
mother's hair at levels over 10 parts per million
appears to be related to developmental and/or
neurological abnormalities in her offspring.
Based upon those findings, the EPAproposes a
reference dose for methylmercuryof0.1 pgper
kilogram bodyweight per day-a figure that is
five times morestringent than thatproposedby
the Agency for Toxic Substances and Disease
Registry (ATSDR) and over four times as
tough as that of the Food and Drug
Administration.
The Seychelle Islands study was designed
as a follow-up to the Iraqi study. Its purpose
was to test the Iraqi findings on a population
thatwas both much larger than the Iraqi pop-
ulation and that received its mercury exposure
through the most common routeofconsump-
tion offish (the Iraqi subjects hadeaten conta-
minated grain). The findings ofthe Seychelles
study, published in volumes 16 and 18 (1995
and 1997, respectively) of Neurotoxicology,
found no evidence that prenatal methylmer-
cury exposure is linked to childhood defects.
However, acompanion studyofsubjects from
the Faroe Islands, published in the
November-December 1997 issue of
Neurotoxicologv and Teratology, indicates that
methylmercury exposure in utero does cause
negative health effects-but not at the rates
noted in the Iraqi study.
The ATSDR has just issued its own draft
report on the health effects of mercury.
Christopher T. DeRosa, director ofthe divi-
sion oftoxicology at the ATSDR, says ofthe
EPA report, "We feel it's a significant body of
work.... Its conclusions are consistent with
conclusions reached by the ATSDR in our
1993 report." DeRosa says that the newest
ATSDR report includes data from the
Seychelle Islands study. The final form ofthe
report will include the data from the Faroe
Islands study, which were not available at the
time thedraftwasdrawn up.
Opponents of the EPA report say the
agency is being overreactive in its play to have
mercury labeled as a significant health threat.
Many ofthese opponents feel the EPA report
will alarm U.S. citizens unnecessarily by lead-
ing them to believe that less, ratherthan more,
Iraqi studya Seychelles Studyb
Studytype Retrospective study Prospective longitudinal study
Number ofparticipants Approximately 80 mothers Over700 motherswith infants
with infants
Medium of exposure Ingestion oftainted grain Ingestion oftainted fish
Exposure duration One exposure episode lasting Low-level, long-term exposures,
several months;few low-level including exposures during
exposures pregnancyand lactation
Method of collecting Used samples ofscalp and Used onlyscalp hair
exposure data non-scalp hair
Method of collecting Self-reporting by participants Collected by health professionals
health effects data using neurobehavioraltests
Methylmercury levels 10to several hundred parts 0.-26.7 parts per million
found in maternal hair permillion
8Neurotoxicol16(4):583-716 (1995) and 18(3):819-829 (1997).
bNeurotoxicol Teratol19(6):417-428 (1997).
mercury will cause health problems, particu-
larlyto those exposed in utero.
Humans are exposed to methylmercury
primarily through eating fish that have accu-
mulated amounts ofthe compound in their
musde tissue. In general, U.S. fish fanciers are
less likely to eat contaminated fish than con-
sumers in other nations. Still, there is some
danger to those who eat large amounts of
seafood, particularly large predatory species
such as shark and swordfish, which are more
likely, through theirposition in the foodchain,
to havebeen exposed to mercurypollution.
The birth ofthe industrial age gave rise to
increased releases ofmercury, thanks to such
developments as electricity, nuclear energy,
and fossil fuel combustion. Mercury tends to
spread widelyand easily because it can remain
suspended in the atmosphere for up to a year.
The organic forms of mercury such as
methylmercury are the more dangerous to
humans because these forms tend to bioaccu-
mulate, as opposed to the inorganic forms,
which tend to be less well absorbed and more
easilydiscarded bythebody.
The uncertainty over whether it is safe to
eat fish and in what amounts is frightening to
many people. To alleviate these fears, DeRosa
says, representatives from anumber ofgovern-
ment agencies, including the EPA, the
ATSDR, and the FDA, will issue ajoint state-
ment later this year that will attempt to pro-
vide a consensus ofwhere the science ofmer-
curypoisoning isheading.
Fighting Disease with Disease
For nearly 200 years, people have observed
that cancers occasionally regress in patients
who contract a bacterial infection. However,
purposely infecting cancer patients with the
same bugs that cause food poisoning and toxic
shock syndrome in order to control their
tumors has never seemed like a very sensible
treatment regimen-until, perhaps, now. In
October, researchers at the Yale University
School of Medicine in New Haven,
Connecticut, announced theyhaddeveloped a
strain of Salmonella typhimurium with an
unusual affinity for malignant tumors. Not
onlydoes this strain limit cancer growthwhile
posing a minimal risk ofserious infection, it
also can be used to deliver anticancer agents to
thesite ofthe tumor.
The result is a Salmonella that attacks
tumors via a two-pronged method, but that
does little or no harm to the patient. In the
Yale study, cancerous mice that received the
bacteria treatment lived up to twice as long as
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cancerous mice that did not, and were found
to have tumors less than halfthe size ofthose
in the untreated mice. The researchers showed
the method to be effective against a wide
range of tumors, including those caused by
inoculating mice with human lung, colon,
breast, kidney, and liver cancers. The
Salmonella even effectively battled multiple
tumors within the same animal, the
researchers reported in the 15 October 1997
issue ofCancerResearch.
The mechanism by which bacterial infec-
tions slow cancer growth is not known, but
investigator John Pawelek and colleagues
Brooks Low and David Bermudes at Yale rea-
soned that ifsuch an infection was localized to
the tumor site, it would slow the cancer
growth more effectivelywhile reducing the risk
of infection elsewhere in the body. By using
different growth substrates, the team was able
to isolate a mutant form of Salmonella that
needs an unusual mix of metabolites to
grow-a mix found in abundance within
malignant tumors but scarcely anywhere else
in the body. Once injected into a cancerous
mouse, the mutant Salmonella seeks out the
tumor and thrives there, while the immune
system easilycontrols the bug in the rest ofthe
body. Sacrificed mice that had undergone
treatment had Salmonella populations in their
tumors that were 250-9,000 times as dense as
thosefound in theanimals' livers.
The deliberate infections dramatically
reduced tumorgrowth, but the authors decid-
ed to take the research a step further. They
reasoned that, because their Salmonella strain
tended to concentrate itselfaround tumors, it
would make agoodvehide fordelivering anti-
cancer drugs. In this vein, the researchers fur-
ther modified the strain by introducing into
the bacteria the herpes simplex virus gene that
codes for thymidine kinase. While thymidine
kinase does not fight cancer on its own, it is
deadly to cells when combined with ganci-
dovir, a prodrug used to fight herpes inAIDS
patients. By a verypoorly understood process,
cells that produce thymidine kinase, such as
the Yale team's modified Salmonella, will not
only die upon contact with gancidovir, they
will take their nearest neighbors with them.
This so-called "bystander effect," which was
first noted a decade ago, has been observed in
many instances ofcell death.
The researchers injected mice with the
Salmonella that incorporated the thymidine
kinase gene, and then treated them with gan-
ciclovir. As expected, additional tumor regres-
sion due to the bystander effect was noted.
However, the researchers reported, this effect
was small in comparison to the much more
radical effect ofthe bacterial infection on the
tumor, despite the efficacy of the drug.
Nonetheless, the use of Salmonella as a drug
delivery device still represents an important
__ Salmo~~~~~~~~~~nella
~~ '~-~~r 'U (outside~~cell)
/
Salmonella i.'(inside cell)
~~ ~ ~ ~ O~ U
WS~~~~~~~~~~~~~~~
(, 9~~~~~~~~~~~~~~~~~~~~~~~~~~~~A
Imelanosomsl ,
Salmonella soldiers? Mice injected with Salmonella show that the bacteria make their way into
melanoma tumor cells and multiply, slowing the growth of the tumor.
breakthrough. Getting drugs into tumors has
always been a difficult challenge for doctors
because, among other barriers, tumors have
high internal pressure pushing outward. But
the Yale scientists showed that for motile
Salmonellasuchobstacles areno problem.
The October report bytheYale group was
the culmination offour years of research on
this radical new method to fight cancer. Now
the scientists are preparing the invention for
use in clinical trials, the next step in drug
development.
Is Airborne Manganese a
Hazard?
Public health officials, scientists, and regula-
tors worry that a gasoline additive containing
manganese, claimed by its maker to boost
engine performance, may cause physical harm
by increasing the amount ofmanganese in the
air. Ethyl Corporation of Richmond,
Virginia, which makes methylcyclopentadi-
enyl manganese tricarbonyl (MMT), disputes
such worries, and says the manganese emitted
into the air when MMT is burned poses no
riskto human health.
The concerns about the additive come as
the Agency for Toxic Substances and Disease
Registry (ASTDR) is completing a toxicologi-
cal profile of manganese to assess sources of
exposure and the metal's impact on health.
The agency is required to prepare such pro-
files for hazardous substances found at the
nation's most serious hazardous waste sites-
those on the EPA's National Priorities List of
Superfund sites. Of1,430 sites on thelist, 644
(or 45%) have "excessive levels of man-
ganese," according to the ATSDR. Excessive
levels are those greater than background in the
environment.
A trace element, manganese is an essential
part of the diet and can easily be obtained
from grains and nuts. Manganese deficiency
can lead to bone problems and stunted
growth. Excess dietary manganese is simply
excreted. A number of studies have shown
that occupational exposure to manganese can
lead to Parkinson's disease-like symptoms
such as musde tremors.
Manganese is used to give strength to steel
and aluminum. Manganese levels in the air
can vary widely, being higher near foundries
and metal plants and lower away from such
facilities. But it's chronic exposure to man-
ganese compounds emitted in the exhaust of
vehides fueled by MMT-boosted gas that has
raised the most concerns.
Canada banned the import ofMMT this
year-none ofthe additive is made there-due
to concerns over possible health effects. MMT
had been used in Canadian gasoline for nearly
20 years. Ethyl is fighting the ban. A U.S.
appeals court in Washington, DC, overturned
an EPA ban on MMT in 1995, saying the
agency acted illegally by attempting to ban the
additive on health grounds under the Clean Air
Act (CAA). The court said that under the CAA,
the EPA could only consider MMYs effect on
engine performance. But California has success-
fully kept the additive out ofunleaded gasoline
sold in that state for approximately 20 years
because ofa "lack ofdata on thehealth effects of
breathing manganese," says Richard Vincent, a
spokesmanfortheCaliforniaAirResourcesBoard.
Widespread exposure to manganese, says
Michael Davis, senior health scientist and act-
ing chief of the EPA's Hazardous Pollutant
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